ScienceDex / Researcher record
John Ramunas
- Rejuvenation Technologies, Inc. (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,183,104 | 2 | #4,590 |
| 2026 | $3,128,890 | 2 | #5,813 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11450512Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing John Ramunas as a PI. Multi-PI records show the full award amount for context.
- 5R44AA028749-03R44Contact PITERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis$1.9Maward amount
- 1R43GM153144-01R43Contact PIClinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells$325Kaward amount
Award organization
Organizations that administered FY2024 awards listing John Ramunas as a PI.
FY2024 award administered by Rejuvenation Technologies, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRejuvenation Technologies, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4590
- 2024Entered Top 25% NationallyRanked #4590
- 2026$5M Cumulative Funding